Fresenius Medical Care AG (FMS)
NYSE: FMS · Real-Time Price · USD
25.66
-0.04 (-0.16%)
At close: Jul 31, 2026, 4:00 PM EDT
25.67
+0.01 (0.04%)
After-hours: Jul 31, 2026, 7:34 PM EDT

Fresenius Medical Care AG Cash Flow Statement

Millions EUR. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
1,1661,191740.87732.46894.331,219
Depreciation & Amortization
1,5691,5001,7421,7521,8381,624
Other Adjustments
139.65229.45115.7579.5985.18299.6
Change in Receivables
-158.1-69.06-73.48-151.84-46.68-163.2
Changes in Inventories
-324.49-248.66107.9-13.14-204.31-48.53
Changes in Accounts Payable
225.8112.45155.59108.48-356.79-363.96
Changes in Income Taxes Payable
209.75236.61482.27472.08325.68313.71
Changes in Other Operating Activities
-143.22-171.47-885.02-350.79-368.39-390.84
Operating Cash Flow
2,7452,6812,3862,6292,1672,489
Operating Cash Flow Growth
13.36%12.36%-9.23%21.29%-12.94%-41.19%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
--915.37-699.36-684.6-723.99-854.36
Sale of Property, Plant & Equipment
16.3116.714.116.1436.2124.42
Purchases of Investments
-76.02-87.52-81.5-102.36-105.64-129.08
Proceeds from Sale of Investments
71.2783.575.1389.657.67144.52
Cash Acquisitions
--21.97-23.07-35.2-59.13-434.17
Proceeds from Business Divestments
184.76202.14629.75172.260.1652.44
Investing Cash Flow
-783.77-722.53-84.94-544.23-734.73-1,196

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
191.04156.4684.8165.34717.091,804
Short-Term Debt Repaid
-163.33-140.81-540.5-244.98-1,302-627.25
Net Short-Term Debt Issued (Repaid)
27.7115.65-455.69-179.64-585.161,177
Long-Term Debt Issued
1,6551,62361.51417.88986.921,244
Long-Term Debt Repaid
-835.04-839.59-834.46-700.66-744.62-2,083
Net Long-Term Debt Issued (Repaid)
819.65782.97-772.95-282.79242.3-838.91
Issuance of Common Stock
----20.156.51
Repurchase of Common Stock
--585.29----
Net Common Stock Issued (Repurchased)
--585.29--20.156.51
Common Dividends Paid
--422.52-349.16-328.62-395.56-392.46
Other Financing Activities
-1,193-1,194-991.5-1,067-899.1-976.49
Financing Cash Flow
-1,701-1,403-2,569-1,859-1,617-1,024

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-100.33-141.4826.2-72.61-23.16131.23
Net Cash Flow
160.46413.79-241.9153.44-207.87400.12

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
2,7451,7661,6871,9441,4431,635
Free Cash Flow Growth
13.36%4.67%-13.24%34.70%-11.73%-48.60%
FCF Margin
14.18%9.00%8.72%9.99%7.44%9.28%
Free Cash Flow Per Share
4.793.032.873.312.462.79
Levered Free Cash Flow
3,1642,191212.921,321841.121,587
Unlevered Free Cash Flow
2,7251,8531,8802,2551,6191,716
SEC Filings: 10-K · 10-Q